A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors
Clinical trial NCT02350673 · COMPLETED
Trial details
- NCT number
- NCT02350673
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-29
- Primary completion
- 2019-12-16
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.